IWO - iShares Russell 2000 Growth ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
212.30
+0.47 (+0.22%)
At close: 4:00PM EDT

212.30 -0.02 (-0.01%)
After hours: 4:13PM EDT

Stock chart is not supported by your current browser
Previous Close211.83
Open211.84
Bid195.68 x 800
Ask0.00 x 1100
Day's Range210.29 - 212.46
52 Week Range162.12 - 214.74
Volume375,284
Avg. Volume653,017
Net Assets10.97B
NAV204.37
PE Ratio (TTM)N/A
Yield0.66%
YTD Return9.62%
Beta (3y)1.17
Expense Ratio (net)0.24%
Inception Date2000-07-24
Trade prices are not sourced from all markets
  • ETF Trends15 days ago

    Growth ETF Responds to Rising Treasury Yields

    While interest rates are climbing, growth stocks and small-caps are delivering impressive performances this year. The iShares Russell 2000 Growth ETF (IWO) marries those two concepts and that exchange traded fund is up nearly 10% year-to-date. The $10.97 billion IWO tracks the Russell 2000 Growth Index, the growth offshoot of the widely followed Russell 2000 Index.

  • Investopedia20 days ago

    Top 3 Small-Cap ETFs for 2018

    There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.

  • 6 Small-Cap ETFs That Have Surged to #1 This Summer
    InvestorPlace23 days ago

    6 Small-Cap ETFs That Have Surged to #1 This Summer

    The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month.Source: Shutterstock

  • Is Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG) a Hot ETF Right Now?
    Zacks2 months ago

    Is Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG) a Hot ETF Right Now?

    Smart Beta ETF report for RZG

  • Analyzing NFLX, GOOGL, and MSFT Stocks
    Market Realist2 months ago

    Analyzing NFLX, GOOGL, and MSFT Stocks

    Netflix’s (NFLX) net income has grown at a three-year and five-year average of 27.9% and 101.1%, respectively. The company’s pre-tax margin grew from 3.9% in 2013 to 4.2% in 2017. The stock prices have beaten the media-diversified industry in 2013, 2015, and 2017. The stock was beaten in 2014 and 2016 by the S&P 500. The market cap had gained 279% between 2013 and 2017.

  • Small-Cap Growth ETF (IWO) Hits New 52-Week High
    Zacks2 months ago

    Small-Cap Growth ETF (IWO) Hits New 52-Week High

    This small-cap ETF hits a new 52-week high. Are more gains in store for this ETF?

  • MiMedx Group on the Street: Analyst Recommendations in January
    Market Realist5 months ago

    MiMedx Group on the Street: Analyst Recommendations in January

    MiMedx Group (MDXG) operates in the regenerative biomaterials segment. MiMedx is a leading global supplier of amniotic tissue products and has supplied over a million allografts in wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. Of the four analysts covering MiMedx Group in January 2018, three have given the stock a “buy” rating, and one analyst has given it a “strong buy” rating.

  • An Insight into Cara Therapeutics’ Drug Pipeline
    Market Realist5 months ago

    An Insight into Cara Therapeutics’ Drug Pipeline

    Cara Therapeutics’ (CARA) investigational drug candidate, CR845, is being developed for providing pain relief. Intravenous (or IV) CR845 has shown a pain relief and tolerability profile in three Phase 2 clinical trials in patients with acute postoperative pain. Cara Therapeutics has initiated a Phase 3 clinical trial program for IV CR845 for postoperative pain in patients undergoing a range of abdominal surgeries.

  • Is US Job Market Getting Too Hot?
    Market Realist5 months ago

    Is US Job Market Getting Too Hot?

    ADP, a human capital management solution provider, releases a monthly report on US non-farm employment. This monthly report is prepared by using actual anonymous payroll data of 411,000 clients that ADP services. The report is released two days before the non-farm payrolls data, so this report prepares markets for any surprises in the jobs report.

  • Array BioPharma’s Financial Performance
    Market Realist6 months ago

    Array BioPharma’s Financial Performance

    What Led to Array BioPharma's Stellar Returns in Past 6 Months

  • Analysts’ Ratings for Radius Health and Its Peers in January
    Market Realist6 months ago

    Analysts’ Ratings for Radius Health and Its Peers in January

    Radius Health (RDUS) is a biopharmaceutical company that has recently turned into a commercial stage healthcare company. Of the seven analysts covering Radius Health in January 2018, three have given the stock “buy” or higher ratings, while four have given it “hold” ratings. The mean rating for the stock is 2.43, and it has a target price of $47.5.

  • Investopedia6 months ago

    Top 3 Small-Cap ETFs for 2018

    There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.

  • What’s behind Insys Therapeutics’ Legal Tangles?
    Market Realist6 months ago

    What’s behind Insys Therapeutics’ Legal Tangles?

    Thus, interaction with government agencies occurs regularly. Insys (INSY) has been a part of several government investigations recently. Insys received a subpoena in December 2013 from the inspector general of HHS for an investigation of potential violations that involved HHS programs.

  • What’s the Potential Market for Accelerate Diagnostics’ Products?
    Market Realist6 months ago

    What’s the Potential Market for Accelerate Diagnostics’ Products?

    How Is Accelerate Diagnostics Positioned at the Start of 2018? Accelerate Diagnostics’ (AXDX) Pheno System utilizes genotypic and phenotypic technology to identify infectious pathogens and perform antibiotic susceptibility tests (or AST), which determine if live bacterial or fungal cells are resistant or susceptible to a particular antimicrobial agent. The kit includes 140 assays for identification and susceptibility testing.

  • Market Realist6 months ago

    US Job Market Isn’t Showing Any Signs of Slowing Down

    As per the ADP National Employment Report, US private sector employment rose by 250,000 jobs in December, a healthy improvement from the 190,000 jobs added in November.

  • Investopedia8 months ago

    Top 3 Small-Cap ETFs for 2017

    There's a case to be made that small-cap ETFs will outperform in the final months of 2017. Here are a few to consider.

  • Dollar Rebounds: 5 ETFs to Cash in On
    Zacks9 months ago

    Dollar Rebounds: 5 ETFs to Cash in On

    Inside five ETFs that could rise in a rising dollar environment.

  • 6 ETFs Set to Win on Trump's Tax Reform
    Zacks9 months ago

    6 ETFs Set to Win on Trump's Tax Reform

    The legislative move has led to the return of Trump trade and investors are cashing in on the opportunity with ETFs that are deemed to gain most on tax reforms.

  • Market Realist10 months ago

    Why Robert Shiller Is Cautious about Equity Markets

    In a recent post by Project Syndicate, Nobel laureate and Yale economics professor Robert Shiller said that stock markets (SPY) are dangerously close to a bear market. Professor Shiller’s cyclically adjusted…...

  • Apple Leads Dow; FANG Gains Fade; Did Gold Flash A Buy Signal?
    Investor's Business Daily10 months ago

    Apple Leads Dow; FANG Gains Fade; Did Gold Flash A Buy Signal?

    Key U.S. stock indexes were slightly higher Tuesday as Apple rose but some other big-cap techs gave up early gains.

  • Apple, Techs Weigh On Stocks; Bitcoin Jumps; Time To Buy Gold?
    Investor's Business Daily10 months ago

    Apple, Techs Weigh On Stocks; Bitcoin Jumps; Time To Buy Gold?

    Key U.S. stock indexes were lower in the stock market today as Apple and other techs fell under pressure.